Publicaciones en colaboración con investigadores/as de Universitat Pompeu Fabra (6)

2016

  1. Possible therapeutic doses of cannabinoid type 1 receptor antagonist reverses key alterations in fragile X syndrome mouse model

    Genes, Vol. 7, Núm. 9

  2. Synaptic plasticity and spatial working memory are impaired in the CD mouse model of Williams-Beuren syndrome

    Molecular Brain, Vol. 9, Núm. 1

2015

  1. Pharmacogenomic study in patients with multiple sclerosis Responders and nonresponders to IFN-β

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e154

2013

  1. Targeting the endocannabinoid system in the treatment of fragile X syndrome

    Nature Medicine, Vol. 19, Núm. 5, pp. 603-607

2012

  1. Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis

    Multiple Sclerosis Journal, Vol. 18, Núm. 7, pp. 983-990

2007

  1. CB1 knockout mice display impaired functionality of 5-HT 1A and 5-HT2A/C receptors

    Journal of Neurochemistry, Vol. 103, Núm. 5, pp. 2111-2120